Allovir Net Income
| ALVRDelisted Stock | USD 9.81 0.26 2.72% |
Allovir technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Allovir's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Allovir's valuation are provided below:Allovir does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Allovir |
Search Suggestions
| AL | Air Lease | Company |
| ALL-PB | The Allstate | Company |
| ALBAX | Alger Growth Income | Mutual Fund |
| ALD | ALD | ETF |
| ALG | ALG | Cryptocurrency |
| ALIUSD | Aluminum Futures | Commodity |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Allovir reported net income of (58.77 Million). This is 117.22% lower than that of the Biotechnology sector and 183.9% lower than that of the Health Care industry. The net income for all United States stocks is 110.29% higher than that of the company.
Allovir Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Allovir's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Allovir could also be used in its relative valuation, which is a method of valuing Allovir by comparing valuation metrics of similar companies.Allovir is currently under evaluation in net income category among its peers.
Allovir Fundamentals
| Return On Equity | -0.8 | |||
| Return On Asset | -0.37 | |||
| Current Valuation | (69.57 M) | |||
| Shares Outstanding | 115.36 M | |||
| Shares Owned By Insiders | 49.11 % | |||
| Shares Owned By Institutions | 42.94 % | |||
| Number Of Shares Shorted | 64.61 K | |||
| Price To Book | 0.43 X | |||
| Gross Profit | 165 K | |||
| EBITDA | (65.44 M) | |||
| Net Income | (58.77 M) | |||
| Cash And Equivalents | 172.67 M | |||
| Cash Per Share | 1.91 X | |||
| Total Debt | 5.24 M | |||
| Debt To Equity | 0.14 % | |||
| Current Ratio | 8.18 X | |||
| Book Value Per Share | 1.05 X | |||
| Cash Flow From Operations | (67.7 M) | |||
| Short Ratio | 26.44 X | |||
| Earnings Per Share | (0.90) X | |||
| Price To Earnings To Growth | (0.06) X | |||
| Target Price | 1.2 | |||
| Beta | 0.74 | |||
| Market Capitalization | 85.25 M | |||
| Total Asset | 118.55 M | |||
| Retained Earnings | (714.96 M) | |||
| Working Capital | 113.31 M | |||
| Current Asset | 61.62 M | |||
| Current Liabilities | 53.23 M | |||
| Net Asset | 118.55 M |
About Allovir Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Allovir's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Allovir using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Allovir based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Allovir Stock
If you are still planning to invest in Allovir check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allovir's history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |